Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Antiparkinson Agents and Homocysteine

Research Papers that Mention the Interaction

In concoction with parkinsonian neurotoxins, Hcy exaggerates dopaminergic neurodegeneration, while its intranigral infusion has been demonstrated to decrease the dopamine level as well as causes dopaminergic neurodegeneration.
Biochimica et biophysica acta  •  2016  |  View Paper
Significantly elevated plasma levels of homocysteine , but not cysteine and cysteinylglycine, were found in treated parkinsonian patients compared to controls.
European Neurology  •  1998  |  View Paper
Additionally, some of the pharmaceuticals currently in clinical practice such as lipid lowering, and anti-Parkinsonian drugs are known to elevate Hcy levels.
Nutrition & Metabolism  •  2017  |  View Paper